67 FR 215 pg. 67521 - New Animal Drugs; Change of Sponsor
Type: RULEVolume: 67Number: 215Page: 67521
FR document: [FR Doc. 02-28156 Filed 11-5-02; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 510, 520, 522, and 524
New Animal Drugs; Change of Sponsor
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for 12 approved new animal drug applications (NADAs) from A. H. Robins Co. to Fort Dodge Animal Health, Division of Wyeth.
DATES:
This rule is effective November 6, 2002.
FOR FURTHER INFORMATION CONTACT:
Lonnie W. Luther, Center for Veterinary Medicine (HFV-104), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 301-827-8549, e-mail: lluther@cvm.fda.gov.
SUPPLEMENTARY INFORMATION:
A. H. Robins Co., P.O. Box 518, Fort Dodge, IA 50501-0518, has informed FDA that it has transferred ownership of, and all rights and interest in, the following 12 approved NADAs to Fort Dodge Animal Health, Division of Wyeth, 800 Fifth St. NW., Fort Dodge, IA 50501:
| NADA Number | Product Name |
|---|---|
| 034-879 | DOPRAM-V Injectable |
| 038-838 | ROBAXIN-V Injectable |
| 045-715 | ROBAXIN-V Tablets |
| 091-065 | ROBIZONE-V |
| 093-105 | ROBIZONE-V |
| 098-640 | ROBIZONE Injectable 20% |
| 101-777 | Robinul-V Injectable |
| 106-111 | Telazol |
| 136-651 | Guailaxin |
| 141-003 | Derm-Otic Ointment |
| 141-004 | Robamox-V |
| 141-005 | Robamox-V Tablets |
Accordingly, the agency is amending the regulations in 21 CFR 520.88b, 520.88f, 520.1380, 520.1720a, 522.775, 522.1066, 522.1085, 522.1380, 522.1720, 522.2470, and 524.1600a to reflect the transfer of ownership and to reflect current format.
Following this change of sponsorship, A. H. Robins Co. is no longer the sponsor of any approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for A. H. Robins Co.
This rule does not meet the definition of "rule" in 5 U.S.C. 804(3)(A) because it is a rule of "particular applicability." Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
List of Subjects
21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.
21 CFR Parts 520, 522, and 524
Animal drugs.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, and 524 are amended as follows:
PART 510-NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as follows:
Authority:
21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
§ 510.600 [Amended]
2. Section 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications is amended in the table in paragraph (c)(1) by removing the entry for "A. H. Robins Co." and in the table in paragraph (c)(2) by removing the entry for "000031".
PART 520-ORAL DOSAGE FORM NEW ANIMAL DRUGS
3. The authority citation for 21 CFR part 520 continues to read as follows:
Authority:
21 U.S.C. 360b.
§ 520.88b [Amended]
4. Section 520.88b Amoxicillin trihydrate for oral suspension is amended in paragraph (c) by removing "000031 and 000093" and by adding in its place "000093 and 000856".
§ 520.88f [Amended]
5. Section 520.88f Amoxicillin trihydrate tablets is amended in paragraph (b) by removing "000031 or 000093" and by adding in its place "000093 and 000856".
§ 520.1380 [Amended]
6. Section 520.1380 Methocarbamol tablets is amended in paragraph (c) by removing "000031" and by adding in its place "000856".
§ 520.1720a [Amended]
7. Section 520.1720a Phenylbutazone tablets and boluses is amended in paragraph (b)(3) by removing "000031".
PART 522-IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS
8. The authority citation for 21 CFR part 522 continues to read as follows:
Authority:
21 U.S.C. 360b.
§ 522.775 [Amended]
9. Section 522.775 Doxapram hydrochloride injection is amended in paragraph (b) by removing "000031" and by adding in its place "000856".
§ 522.1066 [Amended]
10. Section 522.1066 Glycopyrrolate injection is amended in paragraph (b) by removing "000031" and by adding in its place "000856".
§ 522.1085 [Amended]
11. Section 522.1085 Guaifenesin sterile powder is amended in paragraph (b) by removing "No. 000031" and by adding in its place "Nos. 000856".
§ 522.1380 [Amended]
12. Section 522.1380 Methocarbamol injection is amended in paragraph (b) by removing "000031" and by adding in its place "No. 000856".
§ 522.1720 [Amended]
13. Section 522.1720 Phenylbutazone injection is amended in paragraph (b)(1) by removing "000031" and by numerically adding "000856".
§ 522.2470 [Amended]
14. Section 522.2470 Tiletamine hydrochloride and zolazepam hydrochloride for injection is amended in paragraph (b) by removing "000031" and by adding in its place "000856".
PART 524-OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
15. The authority citation for 21 CFR part 524 continues to read as follows:
Authority:
21 U.S.C. 360b.
§ 524.1600a [Amended]
16. Section 524.1600a Nystatin, neomycin, thiostrepton, and triamcinolone acetonide ointment is amended in paragraph (b) by removing "000031" and by numerically adding "000856".
Dated: October 28, 2002.
Andrew J. Beaulieu,
Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 02-28156 Filed 11-5-02; 8:45 am]
BILLING CODE 4160-01-S